Red cell disorders
Gene: NMNAT3
NMNAT is an enzyme that plays a key role in the de novo biosynthesis and salvage of NAD+. Three isoforms of NMNAT exist in mammals (NMNAT1-3), and NMNAT3 is the predominant isoform in RBCs.
PMID:41100733
2 siblings from 1 consanguineous Turkish family with adolescent‑onset hereditary haemolytic anemia, splenomegaly and mild compensated haemolysis. Research based gene panel identified a homozygous variant in NMNAT3 gene (c.64C>T, (p.His22Tyr)) which is absent in gnomAD and located in the adenosine triphosphate (ATP) binding domain. Segregation showed mother was heterozygous and an unaffected sibling was wild-type.
Functional assays demonstrated absent NMNAT activity; decreased levels of NAD+, NADH, NAM, and NMN; and disturbed glycolysis. They noted partial hematologic improvement after NAD precursor supplementation. No contradictory evidence is reported.
PMID: 24739386
They showed that complete knockout of NMNAT3 in mice caused depletion of NAD+ and disturbed glycolytic flow in mature RBCs, resulting in haemolytic anemia and splenomegaly.
Sources: LiteratureCreated: 14 Nov 2025, 3:16 p.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Familial hemolytic anemia, MONDO:0003689
Publications
Gene: nmnat3 has been classified as Red List (Low Evidence).
gene: NMNAT3 was added gene: NMNAT3 was added to Red cell disorders. Sources: Literature Mode of inheritance for gene: NMNAT3 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: NMNAT3 were set to 41100733, 24739386 Phenotypes for gene: NMNAT3 were set to Familial hemolytic anemia, MONDO:0003689 Review for gene: NMNAT3 was set to RED